中慧生物-B(02627)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02627 中慧生物-B

交易中 03-16 10:00:52

52.150

-5.150

-8.99%

最高59.000	最低51.600	成交量21.54万
今开58.000	昨收57.300	日振幅12.91%
总市值204.95亿	流通市值154.55亿	总股本3.93亿
成交额1,152万	换手率0.07%	流通股本2.96亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"中慧生物-B","latestPrice":52.15,"timestamp":1773626446804,"preClose":57.3,"halted":0,"volume":215400,"delay":0,"changeRate":-0.08987783595113435,"floatShares":296361845,"shares":393000000,"eps":-0.8151702584857214,"marketStatus":"交易中","change":-5.15,"latestTime":"03-16 10:00:52","open":58,"high":59,"low":51.6,"amount":11524425,"amplitude":0.129145,"askPrice":52.15,"askSize":600,"bidPrice":51.85,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.7089374060621243,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1773633600000},"marketStatusCode":2,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":57.3,"openAndCloseTimeList":[[1773624600000,1773633600000],[1773637200000,1773648000000]],"volumeRatio":0.924133,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02627","defaultTab":"news","newsList":[{"id":"2619086661","title":"中慧生物-B与香港沃森订立有关亚单位流感疫苗海外市场拓展的战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2619086661","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619086661?lang=zh_cn&edition=full","pubTime":"2026-03-15 15:57","pubTimestamp":1773561420,"startTime":"0","endTime":"0","summary":"　　中慧生物-B发布公告，公司与沃森生物香港有限公司订立有关亚单位流感疫苗海外市场拓展的战略合作协议。根据战略合作协议，双方将就集团研发产品的海外市场注册、销售及商业化开展深度合作。该产品已于2026年一月获准上市，是中国首个且唯一适用于6月龄及以上全人群的三价亚单位流感疫苗。　　董事会认为，香港沃森是海外业务拓展的先行者，拥有丰富的国际化运营经验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-03-15/doc-inhrafps3387127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"1113159933","title":"中慧生物-B核心扩张产品：三价亚单位流感疫苗慧尔康欣3","url":"https://stock-news.laohu8.com/highlight/detail?id=1113159933","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113159933?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:54","pubTimestamp":1773395641,"startTime":"0","endTime":"0","summary":"中慧生物-B（02627）正将其业务扩张的重点聚焦于核心产品——三价亚单位流感疫苗“慧尔康欣3”。该疫苗作为公司战略布局中的关键驱动力，有望在未来市场拓展中发挥重要作用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2619193398","title":"中慧生物-B(02627)与香港沃森订立有关亚单位流感疫苗海外市场拓展的战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2619193398","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619193398?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:49","pubTimestamp":1773395345,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B 发布公告，公司与沃森生物香港有限公司订立有关亚单位流感疫苗海外市场拓展的战略合作协议。根据战略合作协议，双方将就集团研发产品的海外市场注册、销售及商业化开展深度合作。该产品已于2026年一月获准上市，是中国首个且唯一适用于6月龄及以上全人群的三价亚单位流感疫苗。董事会认为，香港沃森是海外业务拓展的先行者，拥有丰富的国际化运营经验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2618936620","title":"每日卖空追踪 | 中慧生物-B 03月10日卖空量成交2800股，卖空比例为0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618936620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618936620?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:30","pubTimestamp":1773131433,"startTime":"0","endTime":"0","summary":"中慧生物-B北京时间03月10日，涨7.14%，卖空量成交2800股，较上一交易日增加100%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163434a6b4d678&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163434a6b4d678&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2618942936","title":"中慧生物-B创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2618942936","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618942936?lang=zh_cn&edition=full","pubTime":"2026-03-10 13:09","pubTimestamp":1773119377,"startTime":"0","endTime":"0","summary":"格隆汇3月10日丨中慧生物-B(02627.HK)涨7.05%，报59.9500港元，股价创历史新高，总市值235.87亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031013101097ab9aa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031013101097ab9aa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2618369939","title":"中慧生物-B盘中异动 下午盘股价大涨5.00%报58.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618369939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618369939?lang=zh_cn&edition=full","pubTime":"2026-03-10 13:03","pubTimestamp":1773119000,"startTime":"0","endTime":"0","summary":"2026年03月10日下午盘13时03分，中慧生物-B股票出现异动，股价急速拉升5.00%。截至发稿，该股报58.800港元/股，成交量141.063万股，换手率0.48%，振幅9.46%。资金方面，该股资金流入4920.54万港元，流出2598.25万港元。中慧生物-B股票所在的生物技术行业中，整体涨幅为4.55%。中慧生物-B公司简介：江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031013032095468ca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031013032095468ca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2618257086","title":"【IPO前哨】诺令生物闯港股：女博士带队，光环与商业化焦虑并存","url":"https://stock-news.laohu8.com/highlight/detail?id=2618257086","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618257086?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:48","pubTimestamp":1773046080,"startTime":"0","endTime":"0","summary":"诺令生物的核心产品iNOwill，打破了这一惯例。诺令生物对此野心勃勃，未来计划构建以iNO为核心的综合生态系统、持续拓宽心肺诊疗产品管线，并积极扩充全球业务版图。诺令生物的商业化表现，未能匹配技术领域的突破。截至2025年9月底，公司账上现金及现金等价物仅剩3001.8万元，另外还有定期存款1.41亿元。截至2025年9月底，公司负债总额达5.57亿元，负债净额达3.22亿元。对于投资者而言，诺令生物的稀缺性毋庸置疑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI2MDAzMTQ4OA==&mid=2650512722&idx=2&sn=c7e7e4c704805537353daff787c53659&chksm=f260e83dc517612b6f939ca941b3bfd4d46c262d5c478ce0ada2eeb5d08af635fe6cafb970d8#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK1161","01875","02315","BK1574","03696","02627","BK1141"],"gpt_icon":0},{"id":"2618261881","title":"中慧生物-B盘中异动 股价大跌5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618261881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618261881?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:31","pubTimestamp":1773019877,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时31分，中慧生物-B股票出现异动，股价急速下挫5.87%。中慧生物-B股票所在的生物技术行业中，整体跌幅为1.93%。其相关个股中，科济药业-B、维立志博-B、派格生物医药-B涨幅较大，振幅较大的相关个股有科济药业-B、药捷安康-B、派格生物医药-B，振幅分别为15.55%、9.51%、8.99%。中慧生物-B公司简介：江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093117a459a19f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093117a459a19f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2616535943","title":"商业化放量在即+研发管线兑现，中慧生物-B(02627)开启第二增长曲线","url":"https://stock-news.laohu8.com/highlight/detail?id=2616535943","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616535943?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:35","pubTimestamp":1772616941,"startTime":"0","endTime":"0","summary":"近日，据公告，中慧生物-B接连迎来两则重磅利好，引发市场关注。在三价疫苗将成为主流的趋势下，中慧生物的三价流感病毒亚单位疫苗以298元/剂的价格成功中标山西省非免疫规划疫苗增补采购项目，成为国内本年度首个中标的全人群三价流感病毒亚单位疫苗。随着商业化产品的持续放量和在研管线的不断兑现，中慧生物将进一步打开未来业绩增长的想象空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409985.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"商业化放量在即+研发管线兑现，中慧生物-B(02627)开启第二增长曲线","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2616173580","title":"中慧生物-B(02627)：mRNA猴痘疫苗获美国FDA许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2616173580","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616173580?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:34","pubTimestamp":1772613268,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B 发布公告，于美国，美国食品药物监督管理局已许可本集团自主研发的在研mRNA猴痘疫苗的临床研究用新药申请。猴痘由猴痘病毒引发，而猴痘病毒是痘病毒科正痘病毒属的一员。在临床前研究中，与中国所用的天花病毒减毒活疫苗天坛株相比，公司的在研mRNA猴痘疫苗引发的猴痘中和抗体水平明显更高，而且它对多种正痘病毒抗原具有广谱交叉反应性。其为中国首款、全球第三款获得FDA的IND许可的在研mRNA猴痘疫苗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409926.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02627","159646"],"gpt_icon":0},{"id":"2616732900","title":"中慧生物-B03月03日主力净流入295.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2616732900","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616732900?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:15","pubTimestamp":1772525759,"startTime":"0","endTime":"0","summary":"03月03日, 中慧生物-B股价涨2.24%，报收52.40元，成交金额1119.3万元，换手率0.07%，振幅4.59%，量比0.67。中慧生物-B今日主力资金净流入295.3万元，上一交易日主力净流出104.5万元。该股近5个交易日下跌0.19%，主力资金累计净流入2362.6万元；近20日主力资金累计净流入5306.7万元，其中净流入天数为17日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162117a69c9c09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162117a69c9c09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2616365477","title":"每日卖空追踪 | 中慧生物-B 03月02日卖空量成交1000股，卖空比例为0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616365477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616365477?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440235,"startTime":"0","endTime":"0","summary":"中慧生物-B北京时间03月02日，跌5.27%，卖空量成交1000股，较上一交易日减少61.54%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163514a730c819&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163514a730c819&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2616365473","title":"中慧生物-B盘中异动 早盘股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616365473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616365473?lang=zh_cn&edition=full","pubTime":"2026-03-02 11:12","pubTimestamp":1772421151,"startTime":"0","endTime":"0","summary":"2026年03月02日早盘11时12分，中慧生物-B股票出现异动，股价快速下跌5.18%。截至发稿，该股报51.300港元/股，成交量17.06万股，换手率0.06%，振幅4.81%。资金方面，该股资金流入388.11万港元，流出384.794万港元。中慧生物-B股票所在的生物技术行业中，整体跌幅为3.87%。中慧生物-B公司简介：江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302111231a4402c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302111231a4402c7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2614189647","title":"每日卖空追踪 | 中慧生物-B 02月27日卖空量成交2200股，卖空比例为1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614189647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614189647?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181033,"startTime":"0","endTime":"0","summary":"中慧生物-B北京时间02月27日，涨2.17%，卖空量成交2200股，较上一交易日减少86.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163433a725f459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163433a725f459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2614016855","title":"差异化创新叠加盈喜预期，中慧生物-B(02627)即将演绎“戴维斯双击”","url":"https://stock-news.laohu8.com/highlight/detail?id=2614016855","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614016855?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:06","pubTimestamp":1772096808,"startTime":"0","endTime":"0","summary":"继今年1月30日宣布公司自主研发的全国首款且唯一的全人群三价流感病毒亚单位疫苗成功获批上市后，中慧生物-B近日再传重磅利好。而此次中慧生物披露年度业绩盈喜，进一步提高了公司长期增长确定性，表明公司在专注创新疫苗升级的同时，已进入商业化兑现期，有望迎来业绩与估值双重提升的“戴维斯双击”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2614015806","title":"中慧生物-B(02627)预计年度营业收入约4.46亿元至4.93亿元 同比增加约71.8%至89.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614015806","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614015806?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:46","pubTimestamp":1772095613,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B 发布公告，集团预期于2025财年录得约人民币4.46亿元至人民币4.93亿元的营业收入，较截至2024年12月31日止年度的人民币2.6亿元营业收入增加约71.8%至89.9%，并预期于2025财年录得约人民币1.57亿元至人民币1.97亿元的净亏损，较截至2024年12月31日止年度的人民币2.59亿元净亏损减少约23.9%至39.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407606.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中慧生物-B(02627)预计年度营业收入约4.46亿元至4.93亿元 同比增加约71.8%至89.9%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627"],"gpt_icon":0},{"id":"1191929658","title":"江蘇中慧元通生物科技股份有限公司2025财年营收介乎446百万元至493百万元，经调整净亏损介乎157百万元至197百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191929658","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191929658?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:46","pubTimestamp":1772095596,"startTime":"0","endTime":"0","summary":"根据公告披露，江蘇中慧元通生物科技股份有限公司2025财年营收有望达到人民币446百万元至人民币493百万元，相比2024财年的人民币259.6百万元同比增长约71.8%至89.9%。同期，经调整净亏损预计为人民币157百万元至人民币197百万元，相较于2024财年人民币258.7百万元的净亏损减少约23.9%至39.3%。同时，伴随持续研发投入及2025年的上市费用增长，整体成本管控取得初步成效，从而使净亏损进一步收窄。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"gpt_icon":0},{"id":"1119682643","title":"中慧生物-B预计2025财年营收区间约为4.46亿至4.93亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1119682643","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119682643?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:45","pubTimestamp":1772095511,"startTime":"0","endTime":"0","summary":"中慧生物-B（股份代号：02627）发布最新业绩指引，预计2025财年将实现营业收入约4.46亿元至4.93亿元人民币。该预测显示出公司对未来业务增长的积极预期，也为投资者提供了明确的财务展望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2614022236","title":"中慧生物-B：盈利预告 - 预期亏损减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2614022236","media":"香港交易所","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614022236?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:43","pubTimestamp":1772095423,"startTime":"0","endTime":"0","summary":"中慧生物发布2025财年业绩预告，预计实现营业收入4.46亿元至4.93亿元，同比增长71.8%至89.9%；预期净亏损收窄至1.57亿元至1.97亿元，同比减少23.9%至39.3%。公司产品质量管理体系持续加强，产品质量批签发合格率达100%，有效降低销售成本。公司2025年新增覆盖232个疾控中心及2,563个接种门诊，扩大了产品销售渠道。虽然研发投入持续，但得益于降本增效措施初见成效，加上收入增长与成本管控的综合效应，使得净亏损进一步收窄。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226231621a722f9be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226231621a722f9be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2614727552","title":"每日卖空追踪 | 中慧生物-B 02月24日卖空量成交6400股，卖空比例为3.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614727552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614727552?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:30","pubTimestamp":1771921831,"startTime":"0","endTime":"0","summary":"中慧生物-B北京时间02月24日，涨1.74%，卖空量成交6400股，较上一交易日减少83.16%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163457a4c23644&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163457a4c23644&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbbio.com","stockEarnings":[{"period":"1week","weight":0.0883},{"period":"1month","weight":0.1566},{"period":"3month","weight":0.3996},{"period":"6month","weight":0.1632},{"period":"1year","weight":3.4419},{"period":"ytd","weight":0.424}],"compareEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":-0.066},{"period":"3month","weight":-0.0197},{"period":"6month","weight":-0.035},{"period":"1year","weight":0.0854},{"period":"ytd","weight":-0.0064}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。该公司的产品管线包括两种核心产品，即四价流感病毒亚单位疫苗及在研冻干人用狂犬病疫苗，以及其他11种在研疫苗。该公司主要在中国市场开展业务。","exchange":"SEHK","name":"中慧生物-B","nameEN":"AB&B BIO-TECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中慧生物-B(02627)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中慧生物-B(02627)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中慧生物-B,02627,中慧生物-B股票,中慧生物-B股票老虎,中慧生物-B股票老虎国际,中慧生物-B行情,中慧生物-B股票行情,中慧生物-B股价,中慧生物-B股市,中慧生物-B股票价格,中慧生物-B股票交易,中慧生物-B股票购买,中慧生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中慧生物-B(02627)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中慧生物-B(02627)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}